The expression of PTPN2 was significantly up-regulated in several cancers (Fig. 2a), it was significantly expressed in almost all types of cancer, especially LAML, ESCA, ALL, and CLL (Fig. 2b). Here, PTPN2 is linked to B-cell chronic lymphocytic leukemia.